Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
LncRNA- Safe contributes to cardiac fibrosis through Safe - Sfrp2 -HuR complex in mouse myocardial infarction
Ist Teil von
Theranostics, 2019-01, Vol.9 (24), p.7282-7297
Ort / Verlag
Australia: Ivyspring International Publisher Pty Ltd
Erscheinungsjahr
2019
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
: As a hallmark of various heart diseases, cardiac fibrosis ultimately leads to end-stage heart failure. Anti-fibrosis is a potential therapeutic strategy for heart failure. Long noncoding RNAs (lncRNAs) have emerged as critical regulators of heart diseases that promise to serve as therapeutic targets. However, few lncRNAs have been directly implicated in cardiac fibrosis.
: The lncRNA expression profiles were assessed by microarray in cardiac fibrotic and remote ventricular tissues in mice with myocardial infarction. The mechanisms and functional significance of lncRNA-
in cardiac fibrosis were further investigated with both
and
models.
: We identified 389 differentially expressed lncRNAs in cardiac fibrotic and remote ventricular tissues in mice with myocardial infarction. Among them, a lncRNA (
) we named
was enriched in the nuclei of fibroblasts, and elevated in both myocardial infarction and TGF-β-induced cardiac fibrosis. Knockdown of
prevented TGF-β-induced fibroblast-myofibroblast transition, aberrant cell proliferation and secretion of extracellular matrix proteins
, and mended the impaired cardiac function in mice suffering myocardial infarction.
studies indicated that knockdown of
significantly inhibited the expression of its neighboring gene
, and vice versa. The
overexpression obviously disturbed the regulatory effects of
shRNAs in both the
cultured cardiac fibroblasts and myocardial infarction-induced fibrosis. Dual-Luciferase assay demonstrated that
and
mRNA stabilized each other via their complementary binding at the 3'-end. RNA electrophoretic mobility shift assay and RNA immunoprecipitation assay indicated that RNA binding protein HuR could bind to
-
RNA duplex, whereas the knockdown of
dramatically reduced the stabilization of
and
mRNAs, down-regulated their expression in cardiac fibroblasts, and thus inhibited TGF-β-induced fibrosis. The
overexpression partially restrained the phenotype change of cardiac fibroblasts induced by
shRNAs, but not that induced by
shRNAs.
: Our study identifies
as a critical regulator of cardiac fibrosis, and demonstrates
-
-HuR complex-mediated
mRNA stability is the underlying mechanism of
-regulated cardiac fibrosis. Fibroblast-enriched
could represent a novel target for anti-fibrotic therapy in heart diseases.